MBCL-21. EARLY CHILDHOOD MEDULLOBLASTOMA: SUBGROUP-SPECIFIC SURVIVAL IN PATIENTS TREATED WITH SYSTEMIC CHEMOTHERAPY AND INTRAVENTRICULAR MTX TO AVOID CRANIOSPINAL RADIOTHERAPY

PURPOSE/METHODS: Methylation-based tumor classification results were obtained from 86 patients younger than four years with medulloblastoma treated with systemic chemotherapy and intraventricular methotrexate to avoid craniospinal radiotherapy (CSI). 70 were HIT trial participants and 16 observation...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Neuro Oncol
Autori principali: Mynarek, Martin, Kool, Marcel, Schueller, Ulrich, von Hoff, Katja, Sharma, Tanvi, Rudneva, Vasilisa, Pietsch, Torsten, Northcott, Paul, Juhnke, B -Ole, Meissner, Barbara, Warmuth-Metz, Monica, Kortmann, Rolf D, Robinson, Giles, von Deimling, Andreas, Pfister, Stefan, Rutkowski, Stefan
Natura: Artigo
Lingua:Inglês
Pubblicazione: Oxford University Press 2018
Soggetti:
Abstracts
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6012787/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy059.417
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi